Status:

UNKNOWN

Blood Draw Study for Liver Transplant Patients

Lead Sponsor:

Baylor Research Institute

Conditions:

Liver Transplant Recipients

Eligibility:

All Genders

17-65 years

Brief Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Detailed Description

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps ...

Eligibility Criteria

Inclusion

  • Received a liver Transplant

Exclusion

  • Received Multiple Organ Transplant

Key Trial Info

Start Date :

October 1 2002

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2015

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01525797

Start Date

October 1 2002

End Date

November 1 2015

Last Update

March 17 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baylor University Medical Center

Dallas, Texas, United States, 752245